FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and is recombinant dietary protein including a polypeptide sequence that is at least 90% identical to a sequence SEQ ID NO:2 for the treatment of a disorder characterized in phenylalanine accumulation in the body of an individual, wherein the specified protein contains (i) all of histidine, arginine, isoleucine, leucine, lysine, methionine, threonine, tryptophan and valine and does not contain phenylalanine.
EFFECT: dietary protein is protein with high biological value that can be used as a drug for the treatment of a disorder characterized in phenylalanine accumulation in the body.
15 cl, 6 dwg, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCOSYLATED FUSED PROTEINS VWF WITH IMPROVED PHARMACOKINETICS | 2017 |
|
RU2782212C2 |
| RECOMBINANT BINDING PROTEINS AND THEIR USE | 2017 |
|
RU2778346C2 |
| POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES | 2017 |
|
RU2776807C2 |
| ANTI-HLA-G ANTIBODIES AND THEIR USE | 2019 |
|
RU2797724C2 |
| RECOMBINANT VIRAL PARTICLES WITH MODIFIED TROPISM AND WAYS OF THEIR USE FOR TARGETED INTRODUCTION OF GENETIC MATERIAL INTO HUMAN CELLS | 2018 |
|
RU2811426C2 |
| METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
| COMBINATION THERAPY USING ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER TREATMENT | 2014 |
|
RU2792932C2 |
| RGMa BINDING PROTEIN AND ITS USE | 2016 |
|
RU2809500C2 |
| PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEPATITIS, LIVER FIBROSIS AND LIVER CIRRHOSIS, INCLUDING FUSION PROTEINS | 2017 |
|
RU2795548C2 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
